These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24043152)

  • 1. Letter by Wallace and Chan regarding article, "Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin".
    Chan MV; Wallace JL
    Circulation; 2013 Sep; 128(12):e190. PubMed ID: 24043152
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Dillinger et al regarding article, "Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin".
    Dillinger JG; Drouet L; Henry P
    Circulation; 2013 Sep; 128(12):e189. PubMed ID: 24043151
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to letters regarding article, "Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin".
    Grosser T; Fries S; Lawson JA; Kapoor SC; Grant GR; Fitzgerald GA
    Circulation; 2013 Sep; 128(12):e191. PubMed ID: 24043153
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin.
    Grosser T; Fries S; Lawson JA; Kapoor SC; Grant GR; FitzGerald GA
    Circulation; 2013 Jan; 127(3):377-85. PubMed ID: 23212718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent FDA warning of the concomitant use of aspirin and ibuprofen and the effects on platelet aggregation.
    Ellison J; Dager W
    Prev Cardiol; 2007; 10(2):61-3. PubMed ID: 17392619
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing aspirin resistance using the Platelet Function Analyzer-100: some methodological caveats and considerations.
    Madsen EH; Schmidt EB; Gehr N; Johannesen NL; Kristensen SR
    J Thromb Haemost; 2008 Feb; 6(2):386-8. PubMed ID: 18036189
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin resistance.
    Tantry US; Mahla E; Gurbel PA
    Prog Cardiovasc Dis; 2009; 52(2):141-52. PubMed ID: 19732606
    [No Abstract]   [Full Text] [Related]  

  • 8. Enteric-coated aspirin: review shows similar inhibition of platelet aggregation to ordinary dispersible aspirin.
    Cardiovasc J S Afr; 2007; 18(1):41, 43. PubMed ID: 17392997
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
    Bondar' TN; Kravchenko NA
    Tsitol Genet; 2012; 46(4):66-72. PubMed ID: 23074965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson F; Reilly MP; Kapoor SC; Cucchiara AJ; DeMarco S; Tournier B; Vyas SN; FitzGerald GA
    N Engl J Med; 2001 Dec; 345(25):1809-17. PubMed ID: 11752357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational use of analgesic and antiinflammatory drugs.
    Crofford LJ
    N Engl J Med; 2001 Dec; 345(25):1844-6. PubMed ID: 11752364
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aspirin resistance theory].
    Porosińska A; Pierzchała K
    Neurol Neurochir Pol; 2006; 40(4):313-9. PubMed ID: 16967353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The concept of aspirin "resistance": mechanisms and clinical relevance].
    Reny JL; Bonvini RF; Barazer I; Berdagué P; de Moerloose P; Schved JF; Gris JC; Fontana P
    Rev Med Interne; 2009 Dec; 30(12):1020-9. PubMed ID: 19595490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
    Cattaneo M
    Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
    [No Abstract]   [Full Text] [Related]  

  • 19. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.